Author:
Jayaweera Dushyantha,DeJesus Edwin,Nguyen Kim L.,Grimm Kristy,Butcher David,Seekins Daniel W.
Subject
Pharmacology (medical),Infectious Diseases
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of raltegravir formulation change on medication adherence and medication errors;Drug Discoveries & Therapeutics;2022-08-31
2. Adherence to HIV treatment regimens: systematic literature review and meta-analysis
;Patient Preference and Adherence;2019-04
3. A case of under-dosing after raltegravir formulation change in an elderly patient treated for HIV;PHARMAZIE;2019
4. Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-08-15
5. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial;The Lancet HIV;2017-11